J&J Kept Quiet on Popular Diabetes Drug as Red Flags Multiplied
RARITAN, New Jersey–Gathered for an emergency meeting, the Johnson & Johnson drug safety team painted an alarming scene: People taking the company’s new blockbuster diabetes drug were falling gravely ill. The drug, Invokana, had been on the market less than …